KUBOTA is a specialist IP firm with particular activity and expertise in the areas of patents and trademarks, thanks to our team of highly qualified and experienced partners and other practitioners. The team includes attorneys-at-law, patent attorneys, and trademark attorneys, many of whom have experience working in research and industry, while several also have professional qualifications obtained overseas.

Our firm has particular strength in patent litigation, especially on matters concerning the hi-tech, pharmaceuticals, and biotech areas. Indeed, the team has been sought out for high-profile disputes, like acting for the Broad Institute in an invalidation action over its Nobel Prize-winning CRISPR/Cas9 gene-editing technology. We also secured a successful settlement for Merck in a patent infringement suit relating to its diabetes drug Januvia (which had sales of over USD 2.2 billion in 2024), brought against a generics manufacturer.

Such matters underline our consistent involvement in high-profile and high-value engagements, as well as our ability to leverage the firm’s well-known expertise in the life sciences sector. The fact we are sought out by many other leading research-based pharmaceutical and biotech companies further underlines our standout reputation for life sciences IP.  


KUBOTA

Org chart

Teams

Offices

KUBOTA

Org chart

Teams

Offices

Related companies